Incyte Corporation (Nasdaq:INCY) announced today it will present at the
Cowen and Company 29th Annual Health Care Conference on
Monday, March 16, 2009 at 3:10 p.m. (Eastern Time).
Paul Friedman, M.D., president and chief executive officer of Incyte,
will provide an overview of the company and discuss its most advanced
drug discovery and development programs.
The presentation will be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts. A replay of the
presentation will be available for 30 days. Investors interested in
listening to the live webcast should log on before the start time in
order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and
development company focused on developing proprietary small molecule
drugs to treat serious unmet medical needs. Incyte's pipeline includes
multiple compounds in Phase I and Phase II development for oncology,
inflammation and diabetes.